Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lappe Mark Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 60 shares @ $25.0208, valued at $1.5k
01/24/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 21,665 shares @ $25.3572, valued at $549.4k
Sold 4,272 shares @ $25.71, valued at $109.8k
Sold 63 shares @ $26.1127, valued at $1.6k
01/03/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Granted 100,000 options to buy @ $23.3, valued at $2.3M
12/20/2022 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 25,246 shares @ $25.5337, valued at $644.6k
Sold 754 shares @ $26.2859, valued at $19.8k
11/18/2022 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 6,959 shares @ $25.3596, valued at $176.5k
Sold 4,106 shares @ $26.5703, valued at $109.1k
Sold 4,333 shares @ $27.4492, valued at $118.9k
Sold 1,767 shares @ $28.8574, valued at $51k
Sold 6,773 shares @ $30.1485, valued at $204.2k
Sold 912 shares @ $30.668, valued at $28k
Sold 1,150 shares @ $32.3837, valued at $37.2k
10/18/2022 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 8,981 shares @ $28.6626, valued at $257.4k
Sold 14,006 shares @ $29.9245, valued at $419.1k
Sold 2,892 shares @ $30.8055, valued at $89.1k
Sold 121 shares @ $31.5071, valued at $3.8k
02/12/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/19/2021 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Gifted 500,000 shares @ $0
Gifted 500,000 shares @ $0
Granted 145,000 options to buy @ $33.63, valued at $4.9M
08/18/2020 3 Lappe Mark (CEO) has filed a Form 3 on Inhibrx, Inc.
03/17/2011 4 Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns: Sold 193,234 shares @ $0.76, valued at $146.9k
Sold 3,799,380 shares @ $0.61, valued at $2.3M
Sold 2,541,000 warrants @ $0.75, valued at $1.9M
02/17/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
02/10/2011 4 Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns: Disposed of 616,450 shares @ $0
Disposed of 776,904 shares @ $0
Disposed of 479,461 warrants @ $0.75, valued at $359.6k
Disposed of 604,258 warrants @ $0.75, valued at $453.2k
12/21/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
12/15/2009 4 Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Sold 126,500 shares @ $0.696, valued at $88k
Sold 77,900 shares @ $0.699, valued at $54.5k
Sold 181,700 shares @ $0.67, valued at $121.7k
12/02/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
11/23/2009 4 Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Sold 214,000 shares @ $0.7487, valued at $160.2k
Sold 215,000 shares @ $0.7069, valued at $152k
Sold 227,000 shares @ $0.7013, valued at $159.2k
05/22/2009 4 Lappe Mark (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy